Nelarabine for Relapsed and Refractory T-ALL/T-LBL
Nelarabine is often used in combination with other chemotherapy agents. Comparing its effectiveness with other treatment options helps healthcare providers determine the best approach for each patient. Nelarabine’s targeted action against T-cells gives it a unique position in the treatment landscape for T-ALL and T-LBL.